Taisho Pharmaceutical Holdings Co., Ltd. 4581.T Stock
Taisho Pharmaceutical Holdings Co., Ltd. Price Chart
Taisho Pharmaceutical Holdings Co., Ltd. 4581.T Financial and Trading Overview
Contents
Taisho Pharmaceutical Holdings Co., Ltd. stock price | 8580 JPY |
Previous Close | 5255 JPY |
Open | 5234 JPY |
Bid | 5390 JPY x 0 |
Ask | 5402 JPY x 0 |
Day's Range | 5234 - 5402 JPY |
52 Week Range | 4925 - 6010 JPY |
Volume | 369.3K JPY |
Avg. Volume | 132.54K JPY |
Market Cap | 441.9B JPY |
Beta (5Y Monthly) | 0.37816 |
PE Ratio (TTM) | 17.653608 |
EPS (TTM) | 0 JPY |
Forward Dividend & Yield | 100 (1.88%) |
Ex-Dividend Date | September 28, 2023 |
1y Target Est | 5440 JPY |
4581.T Valuation Measures
Enterprise Value | 201.92B JPY |
Trailing P/E | 17.653608 |
Forward P/E | 27.914444 |
PEG Ratio (5 yr expected) | -17.33 |
Price/Sales (ttm) | 1.46626 |
Price/Book (mrq) | 0.56176794 |
Enterprise Value/Revenue | 0.67 |
Enterprise Value/EBITDA | 4.236 |
Trading Information
Taisho Pharmaceutical Holdings Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.37816 |
52-Week Change | 3.44% |
S&P500 52-Week Change | 20.43% |
52 Week High | 6010 JPY |
52 Week Low | 4925 JPY |
50-Day Moving Average | 5570.76 JPY |
200-Day Moving Average | 5440.24 JPY |
4581.T Share Statistics
Avg. Volume (3 month) | 132.54K JPY |
Avg. Daily Volume (10-Days) | 142.58K JPY |
Shares Outstanding | 81.99M |
Float | 53.41M |
Short Ratio | N/A |
% Held by Insiders | 40.86% |
% Held by Institutions | 17.40% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 100 |
Trailing Annual Dividend Yield | 1.90% |
5 Year Average Dividend Yield | 153.00% |
Payout Ratio | 0.32759997 |
Last Split Factor | 0.3:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 6.30% |
Operating Margin (ttm) | 7.63% |
Gross Margin | 59.01% |
EBITDA Margin | 15.81% |
Management Effectiveness
Return on Assets (ttm) | 1.57% |
Return on Equity (ttm) | 2.70% |
Income Statement
Revenue (ttm) | 301.38B JPY |
Revenue Per Share (ttm) | 3676.18 JPY |
Quarterly Revenue Growth (yoy) | 8.20% |
Gross Profit (ttm) | N/A |
EBITDA | 47.67B JPY |
Net Income Avi to Common (ttm) | 19B JPY |
Diluted EPS (ttm) | 305.32 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 256.17B JPY |
Total Cash Per Share (mrq) | 3124.77 JPY |
Total Debt (mrq) | 0 JPY |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 5.095 |
Book Value Per Share (mrq) | 9594.709 |
Cash Flow Statement
Operating Cash Flow (ttm) | 40.97B JPY |
Levered Free Cash Flow (ttm) | -13066749952 JPY |
Profile of Taisho Pharmaceutical Holdings Co., Ltd.
Country | Japan |
State | N/A |
City | Tokyo |
Address | 3-24-1 Takada |
ZIP | 170-8655 |
Phone | 81 3 3985 2020 |
Website | https://www.taisho-holdings.co.jp |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) drugs and prescription pharmaceutical products in Japan and internationally. It operates through Self-Medication Operation Group and Prescription Pharmaceutical Operation Group segments. The company offers OTC drugs, quasi-drugs, food products, and general medical and hygiene supplies, such as Lipovitan series of energy drinks; the Pabron series of cold remedies and sinus treatments; the RiUP series of hair re-growth treatment products; the Taisho Kampo series of gastrointestinal treatment products; the Colac series of laxative products; the Naron series and other products for antipyretic analgesics; the Preser series of hemorrhoid treatment products; Hapacol, Efferalgan, Dafalgan, and Tempra for antipyretic analgesics; Counterpain topical anti-inflammatory analgesics; Vitacilina, a dermatological treatment product; and VICKS, a cough suppressant throat lozenges and medicated drops. Further it provides Clarith, a macrolide antibiotic; Bonviva, a bisphosphonate osteoporosis agent; Lusefi, a type 2 diabetes mellitus agent; and LOQOA, a transdermal anti-inflammatory analgesic. The company also offers raw materials for pharmaceuticals and quasi-drugs; and supplies health foods and skin care products, as well as engages in real estate leasing, management, possession, and operation. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is based in Tokyo, Japan.
Q&A For Taisho Pharmaceutical Holdings Co., Ltd. Stock
What is a current 4581.T stock price?
Taisho Pharmaceutical Holdings Co., Ltd. 4581.T stock price today per share is 8580 JPY.
How to purchase Taisho Pharmaceutical Holdings Co., Ltd. stock?
You can buy 4581.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Taisho Pharmaceutical Holdings Co., Ltd.?
The stock symbol or ticker of Taisho Pharmaceutical Holdings Co., Ltd. is 4581.T.
Which industry does the Taisho Pharmaceutical Holdings Co., Ltd. company belong to?
The Taisho Pharmaceutical Holdings Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Taisho Pharmaceutical Holdings Co., Ltd. have in circulation?
The max supply of Taisho Pharmaceutical Holdings Co., Ltd. shares is 81.97M.
What is Taisho Pharmaceutical Holdings Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Taisho Pharmaceutical Holdings Co., Ltd. PE Ratio is 0.00000000 now.
What was Taisho Pharmaceutical Holdings Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Taisho Pharmaceutical Holdings Co., Ltd. EPS is 0 JPY over the trailing 12 months.
Which sector does the Taisho Pharmaceutical Holdings Co., Ltd. company belong to?
The Taisho Pharmaceutical Holdings Co., Ltd. sector is Healthcare.
Taisho Pharmaceutical Holdings Co., Ltd. 4581.T included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
Nikkei 300 N300 | 578.44 JPY 3.9 USD |
+0.57
|
— — | 576.87 JPY 3.89 USD | 579.77 JPY 3.91 USD | — - | — — |
- {{ link.label }} {{link}}